Medicare Enrolled
Dr. Inna Shifrin, MD
Geriatric Medicine (Internal Medicine) Physician · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shifrin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shifrin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shifrin
Dr. Inna Shifrin is a geriatric medicine physician in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shifrin performed 2,757 Medicare services across 1,572 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shifrin received a total of $20,511 from 76 pharmaceutical and/or device companies across 1134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in geriatric medicine (internal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shifrin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in NY
$20,511 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,757
Medicare services
Top 10% in NY for geriatric medicine (internal medicine) physician
1,572
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~138 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
673 | $74 | $175 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
297 | $12 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
225 | $103 | $200 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
203 | $8 | $50 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
144 | $12 | $50 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
137 | $1 | $50 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
134 | $48 | $105 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
126 | $72 | $150 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
109 | $7 | $50 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
107 | $30 | $50 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
100 | $149 | $250 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
87 | $50 | $150 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
86 | $9 | $150 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
76 | $36 | $50 |
| Computerized hearing test with interpretation A hearing test that uses a probe to measure sound responses, followed by a professional review and written report of the results. |
51 | $18 | $80 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 32 | $20 | $50 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
28 | $76 | $150 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
28 | $189 | $350 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
27 | $105 | $200 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
26 | $63 | $162 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $120 | $200 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
18 | $31 | $133 |
| Annual depression screening | 14 | $22 | $200 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
11 | $191 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,511
Total received (2018-2024)
Avg $2,930/year across 7 years
Top 1% in NY for geriatric medicine (internal medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
1,134
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,411 (99.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,930
2023
$3,209
2022
$2,588
2021
$3,022
2020
$2,178
2019
$2,685
2018
$2,900
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$750
ABBVIE INC.
$443
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$343
Lilly USA, LLC
$251
AIMMUNE THERAPEUTICS, INC.
$222
GlaxoSmithKline, LLC.
$207
GENZYME CORPORATION
$206
Philips North America LLC
$181
Novartis Pharmaceuticals Corporation
$143
Abbott Laboratories
$115
Phathom Pharmaceuticals, Inc.
$92
SHIELD THERAPEUTICS INC
$92
Janssen Pharmaceuticals, Inc
$74
Merck Sharp & Dohme LLC
$72
Novo Nordisk Inc
$71
Exact Sciences Corporation
$69
Mylan Specialty L.P.
$65
SANOFI-AVENTIS U.S. LLC
$59
Paratek Pharmaceuticals, Inc.
$56
Corcept Therapeutics
$51
Bausch Health US, LLC
$45
Axsome Therapeutics, Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$32
Alnylam Pharmaceuticals Inc.
$32
E.R. Squibb & Sons, L.L.C.
$29
Regeneron Healthcare Solutions, Inc.
$27
Otsuka America Pharmaceutical, Inc.
$25
Intra-Sana Laboratories
$23
Ardelyx, Inc.
$22
Cumberland Pharmaceuticals, Inc.
$22
Agios Pharmaceuticals, Inc.
$19
Sumitomo Pharma America, Inc.
$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
Esperion Therapeutics, Inc.
$17
Top 3 companies account for 39.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,124
GlaxoSmithKline, LLC.
$1,870
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,598
AbbVie Inc.
$1,146
Lilly USA, LLC
$1,069
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,027
Novo Nordisk Inc
$1,022
SANOFI-AVENTIS U.S. LLC
$995
ABBVIE INC.
$898
Novartis Pharmaceuticals Corporation
$842
Philips Electronics North America Corporation
$550
Genentech USA, Inc.
$469
GENZYME CORPORATION
$413
Janssen Pharmaceuticals, Inc
$322
PFIZER INC.
$321
Mylan Specialty L.P.
$319
Merck Sharp & Dohme LLC
$298
Avanir Pharmaceuticals, Inc.
$296
Merck Sharp & Dohme Corporation
$295
E.R. Squibb & Sons, L.L.C.
$249
AIMMUNE THERAPEUTICS, INC.
$222
Allergan, Inc.
$220
Sunovion Pharmaceuticals Inc.
$213
Philips North America LLC
$181
Astellas Pharma US Inc
$175
Abbott Laboratories
$171
Amarin Pharma Inc.
$170
Exact Sciences Corporation
$131
Ardelyx, Inc.
$129
Teva Pharmaceuticals USA, Inc.
$127
Kowa Pharmaceuticals America, Inc.
$125
Regeneron Healthcare Solutions, Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$120
IBSA Pharma Inc.
$119
Synergy Pharmaceuticals Inc
$114
Amgen Inc.
$113
Sumitomo Pharma America, Inc.
$100
COMSORT, Inc
$100
Esperion Therapeutics, Inc.
$99
Alnylam Pharmaceuticals Inc.
$95
Phathom Pharmaceuticals, Inc.
$92
SHIELD THERAPEUTICS INC
$92
Shield Therapeutics Inc
$90
AbbVie, Inc.
$86
Eisai Inc.
$76
Otsuka America Pharmaceutical, Inc.
$73
Paratek Pharmaceuticals, Inc.
$73
Corium, LLC
$68
Allergan Inc.
$61
SCYNEXIS, Inc.
$52
Corcept Therapeutics
$51
Nestle HealthCare Nutrition Inc.
$48
VIVUS, Inc.
$48
Nabriva Therapeutics, plc
$47
Bausch Health US, LLC
$45
Almatica Pharma LLC
$44
Intra-Sana Laboratories
$41
Axsome Therapeutics, Inc.
$41
Baxter Healthcare
$39
Alfasigma USA, Inc.
$37
SCILEX PHARMACEUTICALS INC.
$30
Purdue Pharma L.P.
$30
Biohaven Pharmaceuticals, Inc.
$28
Currax Pharmaceuticals LLC
$26
Electromed, Inc.
$24
EISAI INC.
$23
Lundbeck LLC
$23
NESTLE HEALTHCARE NUTRITION INC.
$23
Cumberland Pharmaceuticals, Inc.
$22
Agios Pharmaceuticals, Inc.
$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
Melinta Therapeutics, Inc.
$17
Hikma Pharmaceuticals USA
$15
Ironwood Pharmaceuticals, Inc
$15
Clarus Therapeutics Inc.
$14
Mycovia Pharmaceuticals, Inc.
$13
Top 3 companies account for 27.3% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · (AK6) Vest Therapy · (CK7) Extended Holter · ACCRUFER · AIRSUPRA · AJOVY · AMVUTTRA · ANORO ELLIPTA · APLENZIN · AREXVY · Aimovig · Auvelity · Azstarys · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Baxdela · Belviq · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CREON · Cologuard Collection Kit · DUPIXENT · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · GLYXAMBI · Hillrom - Vest System Model 105 Home Care · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · JATENZO · KRISTALOSE · Korlym · LANTUS · LEQVIO · LINZESS · LONHALA MAGNAIR · Licart · Livalo · MOUNJARO · MYRBETRIQ · Mavyret · Mitigare · NAPRELAN · NEXLETOL · NORTHERA · NUCALA · NUEDEXTA · NURTEC ODT · NUZYRA · Nuedexta · Otezla · Ozempic · PANCREAZE · PNEUMOVAX 23 · PYRUKYND · QULIPTA · RELISTOR · RELTONE 200 MG · REXULTI · REYVOW · RYBELSUS · Rybelsus · SEGLENTIS · SHINGRIX · SIVEXTRO · SMARTVEST · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNTHROID · Saxenda · Synthroid · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tirosint · Tresiba · Trintellix · Trulance · UBRELVY · UTIBRON · Utibron · VERQUVO · VOQUEZNA · VRAYLAR · Vascepa · Victoza · Vivjoa · XARELTO · XIFAXAN · XOLAIR · Xenleta · Xofluza · Xolair · YUPELRI · Yupelri · ZENPEP · ZTLido · Zelnorm · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for geriatric medicine (internal medicine) physician in NY.
Geographic Context
Geriatric medicine physicians within 10 mi
378
Per 100K population
14.3
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
1.5 mi
1.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shifrin is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NY), with low-engagement industry engagement in the top 1% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shifrin experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Shifrin performed 673 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shifrin receive payments from pharmaceutical companies?
Yes. Dr. Shifrin received a total of $20,511 from 76 companies across 1,134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shifrin's costs compare to other geriatric medicine physicians in Brooklyn?
Dr. Shifrin's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shifrin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Geriatric Medicine Physicians in Brooklyn
Browse geriatric medicine physicians in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Geriatric Medicine Physicians in NY
Geriatric medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Geriatric Medicine Physicians in NY
Which NY geriatric medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology